분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-12-10 14:16:13 , Hit : 886
 RNA Modification Helps Drosophila Straighten Up and Fly Right

GEN News Highlights

December 9, 2016

Absent a certain RNA modification, the flies folded their wings askew, lost their sense of direction, and wafted about listlessly—more listlessly than is ordinary. The RNA modification that the flies lacked is called m6A, which refers to the methylation of the nitrogen at position 6 of the adenosine base within messenger RNA (mRNA). The wobbly flies? They were part of a molecularly impaired squadron of Drosophila that had been prepared by scientists at the Institute of Molecular Biology (IMB) and Johannes Gutenberg University Mainz (JGU).

The scientists, led by IMB researcher Jean-Yves Roignant, Ph.D., suggest that the m6A RNA modification is important for brain function. They add that since m6A is found in vertebrates as well as in flies, it could also affect brain function in humans.

The scientists presented their findings December 8 in the journal Nature, in an article entitled, “m6A Modulates Neuronal Functions and Sex Determination in Drosophila.” As the title indicates, the scientists didn’t limit their investigation to functions of the nervous system related to locomotion. They also determined that m6A is important to fine-tune sex determination, that is, whether a fly develops as male or female.

“Here we carry out a comprehensive molecular and physiological characterization of the individual components of the methyltransferase complex, as well as of the YTH domain-containing nuclear reader protein in Drosophila melanogaster,” wrote the authors of the Nature article. “We identify the member of the split ends protein family, Spenito, as a novel bona fide subunit of the methyltransferase complex.”

The study enriches our understanding of a recently discovered phenomenon, that RNA modifications are abundant on mRNA. These modifications are roughly analogous to the kinds of modifications that are found on DNA and give rise to epigenetic effects, changes in transcription that do not require alterations in underlying gene sequences. Similarly, RNA modifications may give rise to epitranscriptomic effects, changes in translation that do not require alterations in the underlying gene transcripts.

For our bodies to function normally, it is important for genes to be turned on or off in the right cells at the right times. It is already well established that DNA modifications are important to regulate the activity of genes. These molecular marks on the DNA act as signals to the cell machinery that converts the information contained within a gene into a protein, and help determine how a particular gene is regulated. These signals can be added and removed, which changes whether genes are active or inactive.

Many different modifications have also been identified on RNA, but what they do in vivo was not well understood. m6A is the most prevalent of these RNA modifications, and scientists have shown that it can be added and removed in an analogous way to DNA modifications.

"The discovery that RNA modifications are so abundant on mRNAs was not anticipated until a few years ago,” noted Dr. Roignant. “To my view this is one of the most exciting discoveries in the field in the last 15 years. Our study now sheds light on what they do in living organisms.”

The present publication is the first comprehensive study investigating the role of all components involved in the biogenesis of the m6A RNA modification in a multicellular organism.

“We further demonstrate important roles of this complex in neuronal functions and sex determination, and implicate the nuclear YT521-B protein as a main m6A effector in these processes,” the study’s authors continued. “Altogether, our work substantially extends our knowledge of m6A biology, demonstrating the crucial functions of this modification in fundamental processes within the context of the whole animal.”

The current study is likely to prompt additional work in the emerging field of RNA modifications, or epitranscriptomics. “Now we have found that m6A is there and that it is important for neuronal functions, we want to understand more about its precise role,” said Tina Lence, a Ph.D. student in the Roignant laboratory at IMB and first author of the Nature paper. “For example, is m6A important in all circumstances, or is it more involved in the fine-tuning of gene expression or in response to changes in the environment?”








987   미국 과학·공학·의학 아카데미, 「GM 베이비」의 진행방향에 대한 윤곽 발표  이성욱 2017/02/16 1071
986   Nano-CRISPR Packages Attain 90% Delivery Rate with Engineered Cas9  이성욱 2017/02/09 1328
985   유전자 치료로 청력 되살린다  이성욱 2017/02/08 1350
984   바이러스들도 서로 소통..“상황에 따라 감염방식 결정”  이성욱 2017/01/24 1133
983   Oligonucleotide Therapeutics Near Approval  이성욱 2017/01/10 1168
982   Off Switch Found for Common Version of the CRISPR-Cas9 System  이성욱 2017/01/02 994
981   Editas Expands CRISPR Capabilities through New Technology Licensing  이성욱 2016/12/22 820
  RNA Modification Helps Drosophila Straighten Up and Fly Right  이성욱 2016/12/10 886
979   Anti-CRISPR Protein Is Gene Editing “Off-Switch”  이성욱 2016/12/10 1890
978   Could Gene Therapy Work for Alzheimer’s Disease?  이성욱 2016/10/12 1158
977   EU, 2번째 유전자치료제 ‘스트림벨리스’ 승인  이성욱 2016/09/05 1146
976   DNA Can Be Edited Without Being Cut  이성욱 2016/08/30 1418
975   Using RNA to Amplify RNA  이성욱 2016/08/16 1031
974   CRISPR: No Cutting Required  이성욱 2016/08/06 1636
973   “Kissing Disease” Virus Promotes Malignant Breast Cancer Development  이성욱 2016/08/03 1038
972   Lytic and latent viral replication prevented with CRISPR/Cas9  이성욱 2016/07/27 918
971   Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time  이성욱 2016/07/27 1094
970   FDA OKs AbbVie's once-daily Viekira XR for HCV-1  이성욱 2016/07/27 907
969   [미국] 유전자가위 규제 마련 지연과 기업들의 움직임  이성욱 2016/07/21 1102
968   5년새 20배 성장 `유전자치료제` 시장..경쟁력 확보 필수  이성욱 2016/07/21 986

[이전 10개] [1]..[11][12][13][14] 15 [16][17][18][19][20]..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN